The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
A cytokine-mediated link between innate immunity, inflammation, and cancer
Open accessAbstract
It has been established that cancer can be promoted and/or exacerbated by inflammation and infections. Indeed, chronic inflammation orchestrates a tumor-supporting microenvironment that is an indispensable participant in the neoplastic process. The mechanisms that link infection, innate immunity, inflammation, and cancer are being unraveled at a fast pace. Important components in this linkage are the cytokines produced by activated innate immune cells that stimulate tumor growth and progression. In addition, soluble mediators produced by cancer cells recruit and activate inflammatory cells, which further stimulate tumor progression. However, inflammatory cells also produce cytokines that can limit tumor growth. Here we provide an overview of the current understanding of the role of inflammation-induced cytokines in tumor initiation, promotion, and progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“After chronic stress breaks this balance through a long-term pro-inflammatory response, these cells and cytokines can act on all stages of tumor development, including initiation, promotion, malignant transformation, invasion, and metastasis through mutation, epigenetic modification, and regulation of the tumor microenvironment [(50, 51); Figure 3].”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 12,401
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Research works printed but not linked: 12
- Shacter, 2002, Oncology., 16, 217
- Sehouli, 2002, Anticancer Res., 22, 3421
- Kitakata, 2002, Cancer Res., 62, 6682
- Gado, 2001, Haematologica., 86, 227
- Tartour, 1999, Cancer Res., 59, 3698
- Trinchieri, 2003, Nat. Rev., 3, 133
- Erdman, 2003, Cancer Res., 63, 6042
- Kohno, 2003, Cancer Res., 63, 5091
- Alas, 2001, Clin. Cancer Res., 7, 709
- Lech-Maranda, 2006, Eur. Cytokine Netw., 17, 60
- Parsons, 1995, Cancer Res., 55, 5548
- Engle, 2002, Cancer Res., 62, 6362
Cited by
Sorted by citations
Items 901–999 of 999
Lee, J. M., Tsuboi, M., Kim, E. S., Mok, T. S. K., & Garrido, P. (2022) · Future Oncology · doi:10.2217/fon-2021-1567 · Cited by 28
The Urinary Microbiome: Role in Bladder Cancer and Treatment
Friedrich, V., & Choi, H. W. (2022) · Diagnostics · doi:10.3390/diagnostics12092068 · Cited by 28
Bromfield, J. I., Hugenholtz, P., Frazer, I. H., Khosrotehrani, K., & Chandra, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1091379 · Cited by 27
Beyond the barrier: the immune-inspired pathways of tumor extravasation
Russo, S. D., Liberati, F. R., Riva, A., Fonzo, F. D., Macone, A., Giardina, G., Arese, M., Rinaldo, S., Cutruzzolà, F., & Paone, A. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01429-1 · Cited by 29
Zhou, B., Zhang, P., Tang, T., Liao, H., Zhang, K., Pu, Y., Chen, P., Song, Y., & Zhang, L. (2015) · BMC Cancer · doi:10.1186/s12885-015-1459-7 · Cited by 27
Zhu, J., Zhang, Y., Wu, G., Xiao, Z., Zhou, H., & YU, X. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2643 · Cited by 27
Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer
Muccioli, M., Sprague, L., Nandigam, H., Pate, M., & Benencia, F. (2012) · ISRN Oncology · doi:10.5402/2012/642141 · Cited by 27
Sharma, A., Rajappa, M., Satyam, A., & Sharma, M. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181a8efcc · Cited by 27
Donnini, S., Finetti, F., Terzuoli, E., Giachetti, A., Iñiguez, M. A., Hanaka, H., Fresno, M., Rådmark, O., & Ziche, M. (2011) · Oncogene · doi:10.1038/onc.2011.503 · Cited by 27
Toll-like receptor 2 in promoting angiogenesis after acute ischemic injury
Xu, Y., Zhou, Y., Lin, H., HU, H., Wang, Y., & Xu, G. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1240 · Cited by 26
MUC1 in Macrophage: Contributions to Cigarette Smoke–Induced Lung Cancer
Xu, X., Padilla, M. T., Li, B., Wells, A. C., Kato, K., Tellez, C. S., Belinsky, S. A., Kim, K. C., & Lin, Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1713 · Cited by 27
Chung, M., Jorgensen, S. C., Popova, T. G., Tonry, J. H., Bailey, C., & Popov, S. G. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.007427-0 · Cited by 27
Anti-Inflammatory Effects ofSiegesbeckia orientalisEthanol Extract inIn VitroandIn VivoModels
Hong, Y., Weng, L.-W., Chang, C., Hsu, H., Wang, C.-P., Wang, S., & Houng, J. (2014) · BioMed Research International · doi:10.1155/2014/329712 · Cited by 27
Inhibition of NF-κB in Tumor Cells Exacerbates Immune Cell Activation Following Photodynamic Therapy
Broekgaarden, M., Kos, M., Jurg, F., van Beek, A. A., van Gulik, T. M., & Heger, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160819960 · Cited by 27
CCR7 regulates B16 murine melanoma cell tumorigenesis in skin
Fang, L., Lee, V. C., Cha, E., Zhang, H., & Hwang, S. T. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107776 · Cited by 27
Microbial mysteries: Staphylococcus aureus and the enigma of carcinogenesis
Odunitan, T. T., Apanisile, B. T., Akinboade, M. W., Abdulazeez, W. O., Oyaronbi, A. O., Ajayi, T. M., Oyekola, S. A., Ibrahim, N. O., Nafiu, T., Afolabi, H. O., et al. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106831 · Cited by 27
Tubeimoside-1 attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models
Wu, Q., Sun, G., Xue, Y., Soromou, L. W., Chen, N., Xiong, Y., & Feng, H. (2013) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2013.810643 · Cited by 26
Qiao, L., & Li, X. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.10.013 · Cited by 26
Masuki, S., Nishida, K., Hashimoto, S., Morikawa, M., Takasugi, S., Nagata, M., Taniguchi, S., Rokutan, K., & Nosé, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176757 · Cited by 24
Hasselmo, K., Mehl, M. R., Tackman, A. M., Carey, A. L., Wertheimer, A. M., Stowe, R. P., & Sbarra, D. A. (2018) · Annals of Behavioral Medicine · doi:10.1093/abm/kax034 · Cited by 28
Tan, F. H., Putoczki, T. L., Lou, J., Hinde, E., Hollande, F., Giraud, J., Stylli, S. S., Paradiso, L., Zhu, H., Sieber, O. M., et al. (2018) · Cancers · doi:10.3390/cancers10120526 · Cited by 26
Zhang, D., Li, D., Shen, L., Hu, D., Tang, B., Guo, W., Wang, Z., Zhang, Z., Wei, G., & He, D. (2020) · Oncology Reports · doi:10.3892/or.2020.7496 · Cited by 26
Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors
Wilczyński, J. R., & Nowak, M. (2022) · Experientia supplementum · doi:10.1007/978-3-030-91311-3_1 · Cited by 27
Nunes, E. A., Lomax, A. R., Noakes, P. S., Miles, E. A., Fernandes, L. C., & Calder, P. C. (2010) · Nutrition · doi:10.1016/j.nut.2009.12.008 · Cited by 26
Visconti, L. M., Nelissen, K., Deckx, L., van den Akker, M., Adriaensen, W. J., Daniëls, L., Matheï, C., Linsen, L., Hellings, N., Stinissen, P., et al. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.13.122 · Cited by 26
Immunological effects and therapeutic role of C5a in cancer
Darling, V. R., Hauke, R. J., Tarantolo, S., & Agrawal, D. K. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.983081 · Cited by 26
Kangwan, N., Kim, Y. J., Han, Y. M., Jeong, M., Park, J., Go, E., & Hahm, K. (2015) · Oncotarget · doi:10.18632/oncotarget.6765 · Cited by 26
Agarwal, R., Chaudhary, M. S., Bohra, S., & Bajaj, S. (2016) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/0973-029x.185933 · Cited by 26
Visfatin triggers the in vitro migration of osteosarcoma cells via activation of NF-κB/IL-6 signals
Wang, G., Shen, N., Cheng, L., Fang, Y., Huang, H., & Li, K. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.08.029 · Cited by 26
Sahu, U., Choudhury, A., Parvez, S., Biswas, S., & Kar, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.27 · Cited by 26
The Complex Role of Thrombin in Cancer and Metastasis: Focus on Interactions with the Immune System
Aleksandrowicz, K., Hempel, D., Polityńska, B., Wojtukiewicz, A. M., Honn, K. V., Tang, D. G., & Wojtukiewicz, M. Z. (2023) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0043-1776875 · Cited by 26
Probiotics in colorectal cancer prevention and therapy: mechanisms, benefits, and challenges
Morsli, D. S., Tbahriti, H. F., Rahli, F., Mahammi, F. Z., Nagdalian, A. A., Hemeg, H. A., Imran, M., Rauf, A., & Shariati, M. A. (2025) · Discover Oncology · doi:10.1007/s12672-025-01996-4 · Cited by 26
Dysregulation of over-expressed IL-32 in colorectal cancer induces metastasis
Yang, Y., Wang, Z., Zhou, Y., Wang, X., Xiang, J., & Chen, Z. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0552-3 · Cited by 25
Detectability and reproducibility of plasma levels of chemokines and soluble receptors
Agalliu, I., Xue, X., Cushman, M., Cornell, E. S., Hsing, A. W., Kaplan, R. C., Anastos, K., Rajpathak, S. N., & Ho, G. (2013) · Results in Immunology · doi:10.1016/j.rinim.2013.07.001 · Cited by 25
Liu, B., Yan, S., Jia, Y., Ma, J., Wu, S., Xu, Y., Mingyi, S., & Mao, A. (2016) · FEBS Journal · doi:10.1111/febs.13894 · Cited by 25
Vuong, L. D., Nguyen, Q. N., & Truong, V. (2019) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2019.1569049 · Cited by 25
Nanotechnology synergized immunoengineering for cancer
Chauhan, D. S., Dhasmana, A., Laskar, P., Prasad, R., Jain, N. K., Srivastava, R., Jaggi, M., Chauhan, S. C., & Yallapu, M. M. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.03.010 · Cited by 27
Orlando, A., Colombo, M., Prosperi, D., Gregori, M., Panariti, A., Rivolta, I., Masserini, M., & Cazzaniga, E. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-3148-5 · Cited by 25
Chapter 7 Small Ubiquitin‐Like Modifiers in Cellular Malignancy and Metastasis
Kim, K. I., & Baek, S. H. (2009) · International review of cytology · doi:10.1016/s1937-6448(08)01807-8 · Cited by 26
Xia, X., Park, E., Liu, B., Willette‐Brown, J., Gong, W., Wang, J., Mitchell, D. L., Fischer, S. M., & Hu, Y. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091041 · Cited by 25
IFN-γ (+874) and not TNF-α (−308) is associated with HBV-HCC risk in India
Saxena, R., Chawla, Y. K., Verma, I., & Kaur, J. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1838-9 · Cited by 25
Tada, N., Tsuno, N. H., Kawai, K., Murono, K., Nirei, T., Ishihara, S., Sunami, E., Kitayama, J., & Watanabe, T. (2013) · Oncology Reports · doi:10.3892/or.2013.2857 · Cited by 25
SCF and TLR4 ligand cooperate to augment the tumor-promoting potential of mast cells
Wei, J., Song, C., Sun, L.-C., Yuan, Y., Li, D., Yan, B., Liao, S., Zhu, J., Wang, Q., Zhang, G., et al. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1098-z · Cited by 26
Gao, Y., Theng, S. S., Mah, W.-C., & Lee, C. G. L. (2015) · Biology Open · doi:10.1242/bio.011189 · Cited by 25
Campos, L. S., Rodriguez, Y. I., Leopoldino, A. M., Hait, N. C., Lopez‐Bergami, P., Castro, M. G., Sanchez, E. S., Maceyka, M. W., Spiegel, S., & Alvarez, S. E. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00554-15 · Cited by 25
Yin, Z., Gao, J., Liu, W., Huang, C., Shuai, X., Wang, G., Tao, K., & Zhang, P. (2017) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-017-3385-2 · Cited by 25
Xu, F., Cui, W., Zhao, Z., Gong, W., Wei, Y., Liu, J., Li, M., Li, Q., Chen, Y., Qiu, J., et al. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/7187168 · Cited by 25
Yun, J., Park, M. H., Son, D. J., Nam, K. T., Moon, D. B., Ju, J. H., Hwang, O. K., Choi, J. S., Kim, T. H., Jung, Y. S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0375-6 · Cited by 25
Development of lung cancer in patients with nontuberculous mycobacterial lung disease
Kusumoto, T., Asakura, T., Suzuki, S., Okamori, S., Namkoong, H., Fujiwara, H., Yagi, K., Kamata, H., Ishii, M., Betsuyaku, T., et al. (2018) · Respiratory Investigation · doi:10.1016/j.resinv.2018.11.004 · Cited by 25
Misra, P., & Singh, S. (2019) · Cancer Medicine · doi:10.1002/cam4.2112 · Cited by 25
Paolino, G., Corsetti, P., Moliterni, E., Corsetti, S., Didona, D., Albanesi, M., Mattozzi, C., Lido, P., & Calvieri, S. (2019) · Giornale Italiano di Dermatologia e Venereologia · doi:10.23736/s0392-0488.17.05818-7 · Cited by 27
Tuo, Y., Zhang, Z., Tian, C., Hu, Q.-Y., Xie, R., Yang, J., Zhou, H. W., Lu, L., & Xiang, M. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ma0120-578r · Cited by 25
Role of "cancer stem cells" and cell survival in tumor development and maintenance.Preprint
Adams, J., Kelly, P., Dakic, A., Carotta, S., Nutt, S., & Strasser, A. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.004 · Cited by 21
Kietthubthew, S., Wickliffe, J. K., Sriplung, H., Ishida, T., Chonmaitree, T., & Au, W. W. (2010) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2010.01.002 · Cited by 24
Squamous Metaplasia on the Breast Implant Capsule
Alikhan, M. B., Nassar, A., & Mansoor, I. (2009) · International Journal of Surgical Pathology · doi:10.1177/1066896908329587 · Cited by 24
Auraptene and Its Role in Chronic Diseases
Derosa, G., Maffioli, P., & Sahebkar, A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41342-6_19 · Cited by 24
Anti-inflammatory effect of xanthomicrol, a major colonic metabolite of 5-demethyltangeretin
Guo, S., Wu, X., Zheng, J., Charoensinphon, N., Dong, P., Qiu, P., Song, M., Tang, Z., & Xiao, H. (2018) · Food & Function · doi:10.1039/c8fo00279g · Cited by 24
Yeh, S., Chang, C.-A., Li, C., Wang, L. H.-C., & Chen, B. (2019) · Oncotarget · doi:10.18632/oncotarget.26940 · Cited by 24
Characterization of Ginkgo biloba Leaf Flavonoids as Neuroexocytosis Regulators
Ban, C., Park, J.-B., Cho, S., Kim, H. R., Kim, H. R., Bae, H., Kim, C., Kang, H., Kang, H., Shin, Y. S., et al. (2020) · Molecules · doi:10.3390/molecules25081829 · Cited by 24
Delivery of TSPAN1 siRNA by Novel Th17 Targeted Cationic Liposomes for Gastric Cancer Intervention
Lu, Z., Pang, T., Yin, X., Cui, H., Fang, G., Xue, X., & Luo, T. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.05.018 · Cited by 24
Guo, W., Gao, X., Zhan, R., Zhao, Z., Xu, K., & Tang, B. (2020) · Talanta · doi:10.1016/j.talanta.2020.121525 · Cited by 25
Hua, X., Kratz, M., Malen, R. C., Dai, J. Y., Lindström, S., Zheng, Y., & Newcomb, P. A. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01458-y · Cited by 24
Xu, X., Bai, L., Chen, W., Padilla, M. T., Liu, Y., Kim, K. C., Belinsky, S. A., & Lin, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033846 · Cited by 24
Hönicke, A.-S., Ender, S. A., & Radons, J. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1498 · Cited by 25
Chen, L., Song, J., Qian, Y., Zhao, X., Suo, H., & Li, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15010817 · Cited by 24
Nielsen, L. N., Kjelgaard-Hansen, M. J., & Kristensen, A. T. (2013) · The Veterinary Journal · doi:10.1016/j.tvjl.2013.07.030 · Cited by 24
Mahajna, S., Azab, M., Zaid, H., Farich, B. A., Battah, F. A., Mashner, S., & Saad, B. (2014) · European Journal of Medicinal Plants · doi:10.9734/ejmp/2015/13267 · Cited by 24
Machida, M., & Takemasa, T. (2010) · PubMed · Cited by 24
Fine-Mapping of IL16 Gene and Prostate Cancer Risk in African Americans
Batai, K., Shah‐Williams, E., Murphy, A. B., Newsome, J., Ruden, M., Ahaghotu, C. A., & Kittles, R. A. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0707 · Cited by 24
Plotnikova, M. A., Klotchenko, S. A., & Vasin, A. V. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.01.005 · Cited by 24
Understanding the mode of action of a pterostilbene derivative as anti-inflammatory agent
Nikhil, K., Sharan, S., Palla, S. R., Sondhi, S. M., Peddinti, R. K., & Roy, P. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.05.003 · Cited by 24
Evaluation of coexistence of cancer and active tuberculosis; 16 case series
Çakar, B., & Çiledağ, A. (2017) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2017.11.004 · Cited by 24
Das, R. N., Muruhan, S., Prasad, N. R., & Balupillai, A. (2018) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22263 · Cited by 25
Arzmi, M. H., Cirillo, N., Lenzo, J. C., Catmull, D. V., O’brien-simpson, N. M., Reynolds, E. C., Dashper, S. G., & McCullough, M. J. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy137 · Cited by 24
Liu, P., Jia, S., Lou, Y., He, K., & Xu, L. X. (2019) · International Journal of Hyperthermia · doi:10.1080/02656736.2019.1579373 · Cited by 24
The impact of gut microbiota manipulation with antibiotics on colon tumorigenesis in a murine model
Lee, J. G., Eun, C. S., Jo, S. V., Lee, A.-R., Park, C. H., & Han, D. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226907 · Cited by 24
Cell Therapy as Target Therapy against Colon Cancer Stem Cells
Garza Treviño, E. N., Quiroz Reyes, A. G., Rojas Murillo, J. A., de la Garza Kalife, D. A., Delgado Gonzalez, P., Islas, J. F., Estrada Rodriguez, A. E., & Gonzalez Villarreal, C. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098163 · Cited by 24
Du, J., Romano, R., Si, H., Mattox, A. K., Bian, Y., Yang, X., Sinha, S., Waes, C. V., & Chen, Z. (2013) · The Journal of Pathology · doi:10.1002/path.4302 · Cited by 24
Kim, D. H., Lee, J. H., Park, S., Oh, S., Kim, S., Kim, D. W., Park, K. H., & Kim, K. D. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.04.051 · Cited by 23
Zhu, Z. Y., Song, H., & Xu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.641077 · Cited by 24
Ye, Z., Liang, L., Xu, Y., Yang, J., & Li, Y. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10073-7 · Cited by 23
Yu, Z., Peng, Y., Gao, J., Zhou, M., Shi, L., Zhao, F. H., Wang, C., Tian, X., Feng, L., Huo, X., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade0387 · Cited by 24
Lin, W., Yeh, S., Yang, W., Yeh, K., Fujiwara, T., Nii, A., Chang, S., & Chen, P. (2012) · International Journal of Cancer · doi:10.1002/ijc.27770 · Cited by 23
Self-citationThe expression of leucine-rich repeat gene family members in colorectal cancer
Piepoli, A., Palmieri, O., Maglietta, R., Panza, A., Cattaneo, E., Latiano, A., Laczkó, E., Gentile, A., Carella, M., Mazzoccoli, G., et al. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.012042 · Cited by 23
TNF-α and IGF-1 differentially modulate ionizing radiation responses of lung cancer cell lines
Pal, S., Yadav, P., Sainis, K. B., & Shankar, B. S. (2016) · Cytokine · doi:10.1016/j.cyto.2016.06.015 · Cited by 23
Li, D., Guo, J., Wang, S., Zhu, L., & Shen, Z. (2017) · Oncology Letters · doi:10.3892/ol.2017.6506 · Cited by 23
IFN-γ and other serum cytokines in head and neck squamous cell carcinomas
Bussu, F., Graziani, C., Gallus, R., CITTADINI, A., Galli, J., Corso, E. D., Cintio, G. D., Corbi, M., Almadori, G., Boninsegna, A., et al. (2018) · Acta Otorhinolaryngologica Italica · doi:10.14639/0392-100x-1530 · Cited by 23
SERUM CYTOKINE OF IL-2, IL-10 AND IL-12 LEVELS IN PATIENTS WITH STOMACH ADENOCARCINOMA
Shokrzadeh, M., Mohammadpour, A., Hoseini, V., Abediankenari, S., Ghassemi-Barghi, N., & Tabari, Y. S. (2018) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.201800000-83 · Cited by 23
Diagnostic and prognostic value of serum IL-23 in colorectal cancer
El‐Essawi, D. F., Alkady, M. M., & Ibrahim, I. M. (2019) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2019.05.002 · Cited by 24
Hu, J., & Cheng, H. W. (2021) · Poultry Science · doi:10.1016/j.psj.2021.101294 · Cited by 23
Wei, C., Tsai, I., Wu, C., Hung, W., Hsuan, C., Yu, T., Hsu, C., Houng, J., Chung, F., Lee, Y., et al. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.58789 · Cited by 23
Cytokine effects on cell survival and death of A549 lung carcinoma cells
Kastamoulas, M., Chondrogiannis, G., Kanavaros, P., Vartholomatos, G., Bai, M. C., Briasoulis, E. C., Arvanitis, D. L., & Galani, V. (2013) · Cytokine · doi:10.1016/j.cyto.2013.01.017 · Cited by 23
Shim, J. W., Jo, S. H., Kim, S. D., Lee, H. Y., Yun, J., & Bae, Y. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.8.064 · Cited by 23
Polymorphisms in the CHIT1 gene: Associations with colorectal cancer
Li, F.-F., Yan, P., Zhao, Z., Liu, Z., Song, D., Zhao, X., Wang, X., Wang, G., & Liu, S. (2016) · Oncotarget · doi:10.18632/oncotarget.9138 · Cited by 23
Control of polarization and tumoricidal activity of macrophages by multicellular spheroid formation
Tanaka, Y., Nishikawa, M., Mizukami, Y., Kusamori, K., Ogino, Y., Nishimura, S., Shimizu, K., Konishi, S., Takahashi, Y., & Takakura, Y. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.006 · Cited by 23
A Novel Antiangiogenic Effect for Telomerase-Specific Virotherapy through Host Immune System
Ikeda, Y., Kojima, T., Kuroda, S., Endo, Y., Sakai, R., Hioki, M., Kishimoto, H., Uno, F., Kagawa, S., Watanabe, Y., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1763 · Cited by 23
Medeiros, M. K., Zheng, X., Novák, P., Wnek, S. M., Chyan, V., Escudero‐Lourdes, C., & Gandolfi, A. J. (2011) · Toxicology · doi:10.1016/j.tox.2011.11.002 · Cited by 23
Kangwan, N., Kim, Y. T., Han, Y., Jeong, M., Park, J., & Hahm, K. (2015) · International Journal of Cancer · doi:10.1002/ijc.29892 · Cited by 22
Xie, Z., Guo, Z., & Liu, J. (2018) · Medical Science Monitor · doi:10.12659/msm.907176 · Cited by 22
Metadata
- Authors
- Lin, W.-W., & Karin, M.
- Affiliations
- National Taiwan University (TW)
- University of California San Diego (US)
- Corresponding author
- Karin, Michael
- Venue
- Journal of Clinical Investigation
- Published
- 2007-05-01
- Volume
- 117
- Issue
- 5
- Pages
- 1175-1183
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1857251
- OpenAlex
- W2133439754
- Cited by
- 1,940
- References
- 128
- Citations by year
- 2026: 18 · 2025: 39 · 2024: 60 · 2023: 92 · 2022: 93 · 2021: 117 · 2020: 117 · 2019: 102 · 2018: 93 · 2017: 123 · 2016: 104 · 2015: 127 · 2014: 134 · 2013: 130 · 2012: 124
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- cytokines, innate immunity, inflammation, cancer, chronic inflammation, tumor microenvironment, tumor promotion, tumor progression, infection and cancer, tumor initiation, inflammatory cells
- MeSH terms
- Animals, Humans, Immunity, Innate, Inflammation, Neoplasms, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review